NHWD-870 has many beneficial properties, including inhibition of tumor proliferation by inhibiting BRD4 and c-MYC transcription, inhibition of tumor-associated macrophages (TAM) development, and reduction of CSF-1 (colony-stimulating factor) secretion by tumor cells [189,190]. The gene discussed is CSF2; the disease is neoplasm.